Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

ERA-NET: Sustained collaboration of national and regional programmes in cancer research

Description du projet

DE EN ES FR IT PL

Vingt pays unissent leurs forces contre le cancer

La recherche translationnelle sur le cancer revêt une importance essentielle pour aborder, comprendre et prévenir le cancer, qui demeure un problème de santé mondial malgré les progrès constants de la recherche et des approches thérapeutiques. Le projet TRANSCAN-3, financé par l’UE, rassemble 31 organismes de financement issus de 20 pays et ayant pour objectif commun de soutenir une recherche translationnelle sur le cancer avec un impact élevé. En lançant des appels à propositions conjoints transnationaux et en exploitant pleinement les coopérations internationales et interrégionales, TRANSCAN-3 entend apporter des contributions marquantes ainsi qu’un modèle de financement durable pour une recherche translationnelle révolutionnaire sur le cancer, en Europe et ailleurs.

Objectif

Cancer is a worldwide health burden and a major public health challenge. Despite significant advances in the understanding, prevention, diagnostics and treatment, cancer remains a public health problem in Europe and the world. In such a setting, translational cancer research plays a key role in successfully addressing the growing burden of cancer.

The great potential of translational cancer research in Europe will only be achieved when the main barriers are systematically addressed through concerted actions between public and private organisations that provide funds for research, researchers, healthcare providers and all those engaged in the cancer research spectrum. Moreover, adequate and systematic financial support backed by a strong political commitment is absolutely essential to help reduce the burden of cancer that European citizens are currently facing.

In this context, the TRANSCAN-3 network, with a strong background in funding cancer research, embodies an excellent model of cross-national cooperation by bringing together 31 funding organisations, from 20 countries, with the common goal of supporting high-impact translational cancer research through cross-national joint calls for proposals, and by an efficient investment of dedicated national/regional public funding, leveraged with foundation/charity-based resources and EU financial support.

Building up on the well-established cooperation and accomplishments, through the harmonisation of national/regional funding mechanisms and programmes, plus continued and sustained series of efforts for the access to and sharing of data on cancer research, this TRANSCAN-3 project also aims at becoming a catalysts for a sustainable model of funding of high-impact cancer research in Europe and beyond, with an approach to effectively engage relevant stakeholders (patients, society as a whole, policy makers, etc.) in different stages of the action.

Mots‑clés

Programme(s)

Thème(s)

Régime de financement

ERA-NET-Cofund - ERA-NET Cofund

Coordinateur

MINISTERO DELLA SALUTE
Contribution nette de l'UE
€ 1 783 692,90
Adresse
Via Giorgio Ribotta 5
00144 Roma
Italie

Voir sur la carte
Région
Centro (IT) Lazio Roma
Type d’activité
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Liens
Coût total
€ 5 405 130,00

Participants (30)

Partager cette page Partager cette page sur les réseaux sociaux

Télécharger Télécharger le contenu de la page

Dernière mise à jour: 26 Decembre 2024

Mon livret

Permalink: https://cordis.europa.eu/project/id/964264/fr

European Union, 2025